Glucose regulates amyloid β production via AMPK
- 13 June 2015
- journal article
- research article
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 122 (10) , 1381-1390
Abstract
Alzheimer’s disease (AD) is the most common form of dementia in the elderly. Accumulation of Aβ peptides in the brain has been suggested as the cause of AD (amyloid cascade hypothesis); however, the mechanism for the abnormal accumulation of Aβ in the brains of AD patients remains unclear. A plethora of evidence has emerged to support a link between metabolic disorders and AD. This study was designed to examine the relationship between energy status and Aβ production. Neuro 2a neuroblastoma cells overexpressing human amyloid precursor protein 695 (APP cells) were cultured in media containing different concentrations of glucose and agonist or antagonist of AMP-activated-protein-kinase (AMPK), a metabolic master sensor. The results showed that concentrations of glucose in the culture media were negatively associated with the activation statuses of AMPK in APP cells, but positively correlated with the levels of secreted Aβ. Modulating AMPK activities affected the production of Aβ. If APP cells were cultured in high glucose medium (i.e., AMPK was inactive), stimulation of AMPK activity decreased the production levels of Aβ. On the contrary, if APP cells were incubated in medium containing no glucose (i.e., AMPK was activated), inhibition of AMPK activity largely increased Aβ production. As AMPK activation is a common defect in metabolic abnormalities, our study supports the premise that metabolic disorders may aggravate AD pathogenesis.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (102-2314-B-214-006-MY3)
- Ministry of Science and Technology, Taiwan (101-2320-B-006-006-MY3)
This publication has 57 references indexed in Scilit:
- Neuronal activity regulates the regional vulnerability to amyloid-β depositionNature Neuroscience, 2011
- Insulin-resistant brain state: The culprit in sporadic Alzheimer's disease?Ageing Research Reviews, 2011
- Structure of mammalian AMPK and its regulation by ADPNature, 2011
- AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer’s disease and other tauopathiesActa Neuropathologica, 2010
- How does diabetes accelerate Alzheimer disease pathology?Nature Reviews Neurology, 2010
- Involvement of AMP-activated-protein-kinase (AMPK) in neuronal amyloidogenesisBiochemical and Biophysical Research Communications, 2010
- Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic miceExperimental Neurology, 2010
- Antidiabetic drug metformin (Glucophage R ) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcriptionProceedings of the National Academy of Sciences, 2009
- The Role of Metabolic Disorders in Alzheimer Disease and Vascular DementiaArchives of Neurology, 2009
- Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer diseaseFEBS Letters, 2008